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protocol Article
Protocol for a randomised clinical trial of 
transoral ultrasound versus standard of care  
in the diagnosis of peritonsillar abscess
The progression of peritonsillar cellulitis (PTC) to a 
peritonsillar abscess (PTA) – defined as a collection of 
pus in the loose connective tissue between the palatine 
tonsil and the pharyngeal muscles – is the most com­
mon head and neck infection requiring hospitalisation 
[1]. Patients have typically suffered from a prolonged 
case of acute tonsillitis and complain of unilateral sore 
throat, ipsilateral ear pain and decreased oral intake 
[2]. Objective findings consistent with a PTA include a 
muffled voice, trismus, a swollen tonsil and deviation 
of the uvula to the opposite side of the PTA [3]. Early 
surgical drainage is imperative to avoid a potentially 
dangerous spreading of the PTA into the surrounding 
tissue [4]. The abscess can be drained under local an­
aesthesia by needle aspiration or knife incision [5]. 
Most commonly, the point of maximal protrusion and 
fluctuance will guide the insertion of the needle or scal­
pel. If no pus is aspirated, the instrument is inserted 
once or twice more, guided by specific landmarks (the 
landmark technique) [2, 6]. Distinguishing a PTA from 
PTC based on a standard clinical examination is diffi­
cult (sensitivity 78%, specificity 50%) [7]. A PTA may 
therefore be missed, or unnecessary PTC drainage at­
tempts will therefore often be performed [8]. Further­
more, unsuccessful needle aspirations may also be seen 
in patients with a small or more posteriorly located abs­
cess cavity. A computed tomography with contrast can 
ensure a correct diagnosis, but is expensive and ex­
poses the, often young, patients to ionising radiation. 
Instead, point­of­care ultrasound can provide a fast, ra­
diation­free and low­cost imaging [9]. Previously pub­
lished case series and retrospective cohort studies have 
described that transoral ultrasound with an endocavity 
or “hockey stick” transducer can increase the diagnostic 
accuracy [10­14]. Only one small single­centre ran­
domised controlled trial has been conducted, but their 
technique only allowed for static ultrasound imaging 
and not for real­time guidance of the needle aspiration 
[15]. For this reason, we have developed a new tech­
nique which utilises a small neurosurgical ultrasound 
transducer suitable for transoral ultrasound­guided as­
piration of PTAs [16]. The hypothesis is that we can im­
prove the diagnostic accuracy and treatment of patients 
referred with a PTA by adding a novel point­of­care 
transoral ultrasound technique to the standard clinical 
examination. The research question is: In a group of pa­
tients referred to an otolaryngology department with 
objective signs of a peritonsillar abscess, what is the ef­
fect of using transoral ultrasound to diagnose PTA and 
guide needle aspiration when measured by the diag­
nostic accuracy, the proportion of successful needle as­
pirations and the total number of performed needle as­
pirations. This effect is compared with the effect in 
ABSTRACT
INTRODUCTION: Peritonsillar infection is a common compli­
cation to acute tonsillitis in younger adults. If peritonsillar 
cellulitis progresses to a peritonsillar abscess (PTA), the 
primary treatment is surgical drainage. But disting uishing 
cellulitis from PTA on a standard clinical examination is diffi­
cult. This trial aims to explore whether point­of­care trans­
oral ultrasound can improve diagnostic accuracy and guide 
successful needle aspiration in patients referred with PTA. 
METHODS: A randomised, controlled multicentre trial will be 
conducted at the departments of otorhinolaryngology, head 
and neck surgery at Rigshospitalet and Odense University 
Hospital. Patients referred with PTA will be randomised to 
either standard clinical examination (control) or standard 
clinical examination with supplemental transoral ultrasound 
(intervention). The diagnostic accuracy, the total number of 
performed needle aspirations and the proportion of suc­
cess ful needle aspirations will be compared between the 
two groups. The difference will be evaluated using binary 
logistic regression and a generalised estimating equation to 
adjust for clustering of data within each physician and each 
hospital. A total of 88 patients are necessary to measure the 
clinical effect of adding transoral ultrasound. 
CONCLUSIONS: This study will explore the clinical benefits 
of adding transoral ultrasound to the diagnostic work­up of 
patients with peritonsillar infections. 
FUNDING: The Rigshospitalet and Odense University 
Hospital Foundation. 
TRIAL REGISTRATION: Clinicaltrials NCT03824288.
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patients diagnosed using a standard clinical examin­
ation and treated using the traditional landmark­based 
needle aspiration technique. 
 
METHODS
The study is a prospective, randomised, controlled mul­
ticentre trial conducted at two university hospitals in 
Denmark (the Department of Otorhinolaryngology – 
Head & Neck Surgery and Audiology, Odense Univer­
sity Hospital (OUH), and the Department of Otorhino­
laryngology, Head and Neck Surgery & Audiology, 
Rigshospitalet (RH)). The protocol is registered with 
clinicaltrials.gov (Trial number: NCT03824288) and 
adheres to the recommendations for interventional tri­
als described in the SPIRIT 2013 Checklist.
Eligibility criteria
In Denmark, patients suspected of having a PTA are 
typically first examined by a general practitioner or a 
physician from an emergency department. Once suspi­
cion of PTA has been raised, they are referred to an of­
fice­based otolaryngologist or a hospital­based depart­
ment of otolaryngology. Patients referred to the two 
participating departments of otolaryngology, head and 
neck surgery on suspicion of having a PTA will be in­
vited to participate in the study only if the resident on 
call has been trained in the procedure of ultrasound­
guided PTA drainage. Patients who meet both the eligi­
bility and the inclusion criteria (see Table 1) and agree 
to participate in the study will be allocated to the inter­
vention or control group using a 1:1 randomisation. 
Randomisation
Before the study begins, a randomisation list will be 
created using a random permuted blocks technique 
available online. Based on the randomisation list, 
sealed envelopes containing the equipment needed for 
either the intervention or the control group will be pre­
pared and provided with a consecutive patient inclu­
sion number. Once patient consent has been obtained, 
included patients will be allocated to either the control 
or the intervention group in accordance with the con­
tents of the sealed envelope.
Interventions
All included patients will receive the same physical oto­
rhinolaryngology examination, including a flexible 
transnasal laryngoscopy and an objective measure of 
the degree of trismus based on a TheraBite range of 
motion scale. All patients will receive a minimum of 
one spray of topical anaesthetic (lidocaine 10 mg/
dose) to the posterior pharynx. If needle aspiration is 
deemed necessary, 0.5 ml of 2% lidocaine with 5 µg  
epinephrine will subsequently be injected into the mu­
cous membrane. If the PTA aspiration produces pus, 
this will be collected in a test tube with a transport me­
dium suitable for aerobic and anaerobic bacteria and 
sent for microbiological examination. A mosquito for­
ceps will then be introduced to open the abscess cavity 
further to aid additional drainage. If no needle aspira­
tion is performed, or if a needle aspiration produces no 
pus, a swap of the affected tonsil is made and sent for 
microbiological examination. All patients will either be 
seen in the outpatient clinic 24­36 hours after their first 
consultation or be admitted to the hospital according to 
their general condition. The patients who refuse to par­
ticipate in the study will receive the standard treat­
ment, which is identical to that of the control group. 
About a month after the discharge from the outpa­
tient clinic/hospital, patients will receive a phone call 
from one of the co­authors inquiring about their total 
number of sick days (defined as days until they re­
turned to work/school or believe that they would have 
returned if they were sick during vacation/holydays).
Control group
A standard examination of the oral cavity is performed, 
and if the clinical findings are consistent with a PTA, a 
needle aspiration is attempted. The needle is inserted 
into the point of maximal protrusion and fluctuance, 
which most commonly corresponds to the superior pole 
of the tonsil [2]. If the initial aspiration is unsuccessful, 
up to two additional attempts – typically in the middle 
and lower pole of the tonsil – may be made. If all at­
tempts are unsuccessful, the patient will either be dis­
charged with penicillin V and a planned follow­up visit 
in the outpatient clinic or be admitted to the otorhino­
laryngology department for treatment with intravenous 
antibiotics or quincy tonsillectomy – depending on the 
severity of the symptoms and clinical findings. 
 
Intervention group
The otorhinolaryngologist on call will perform a stand­
ard oral examination, apply topical anaesthetics to the 
posterior pharynx and subsequently conduct a trans­
TABLE 1 / Eligibility criteria for enrollment of study participants..
criteria Description
Inclusion criteria Patients referred to the department of otorhinolaryngology on the suspicion of 
having a peritonsillar abscess, who also present ≥ 1 of the following on clinical 
examination
Unilateral tonsillar protrusion
Peritonsillar swelling 
Trismus
Exclusion criteria Age < 18 yrs  
Compromised airways or suspected retro-/parapharyngeal abscess
Needle aspiration already performed or participated in the study 1 × earlier
Unable to understand the verbal or written information
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oral ultrasound examination using a bk5000 machine 
and a Burr­Hole N11C5s transducer from BK Medical. 
The transducer is placed in a surgical glove filled with 
ultrasound gel. The tip of the transducer is then placed 
on the palatoglossal arch and swept from the cranial to 
the caudal end of the affected tonsil. An abscess is ex­
pected to appear as a hypoechoic area with ill­defined 
margins. If an abscess is not clearly visualised, the 
slightly larger high­frequency Hockey Stick X18L5 
transducer may be applied to obtain a higher resolution 
image. If an abscess cavity is suspected, local anaesthe­
sia is injected into the mucosa, and an ultrasound­
guided needle aspiration is attempted. The aspiration 
technique chosen will depend on the degree of trismus 
and the severity of the gag reflex. The needle aspiration 
will therefore either be performed with an in­plane 
needle guide attached to a Burr­Hole N11C5s trans­
ducer, (b) an ultrasound­guided free­hand technique 
or (c) a “blind” aspiration guided by the previously 
visu alised abscess on the static ultrasound image, see 
Figure 1. If the initial aspiration is unsuccessful, up to 
two additional attempts may be made. If no abscess 
cavity is visualised, no needle aspiration is attempted. 
Instead, the patient is handled like the patients in the 
control group after three unsuccessful needle aspir­
ation attempts. 
Training in transoral ultrasound 
Surgeon­performed ultrasound is an integrated part of 
the diagnostic work­up at otolaryngologists in Den­
mark and the residents therefore receive head and neck 
ultrasound training early in their residency. Before they 
can include patients in the study, they must participate 
in an additional 45­minute intensive simulation train­
ing of ultrasound­guided PTA aspiration. First, they 
will attend a short didactic lecture by author TT, and 
then they will receive hands­on training on a custom­
made artificial PTA model, taught by either TT or SHM, 
see Figure 2. The artificial PTA consists of a cup filled 
with hardened gelatin (the “pharyngeal muscles”) into 
which two small water balloons (two “abscesses”) have 
been placed [17]. All residents must perform two ultra­
sound­guided aspiration attempts: one with a needle­
guide attached to the ultrasound transducer and the 
other with a free­hand technique. 
Clinical outcome measures
These baseline characteristics between the interven tion 
and the control group will be compared: sex, smoking 
habits, level of pain on presentation, num ber of cases of 
acute tonsillitis during the past year, previous number 
of PTAs. 
Primary outcome will be reported as:
• Diagnostic accuracy
• Part of successful (with pus) needle aspir ations
• Total number of performed needle aspirations in 
each group.
 
Secondary outcomes will be: 
• Number of sick days 
• Number of days of hospitalisation 
FIGURE 1 / Transoral ultrasound image from a patient with 
a peritonsillar abscess (white and yellow measuring lines on the 
image).
FIGURE 2 / Simulation training of ultrasound-guided peritonsillar abscess aspiration 
on a custom-made peritonsillar abscess gelatine phantom placed in the oral cavity of a  
mannequin for airway management.
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• Number of quincy tonsillectomies (tonsillectomy  
“a chaud”)
• Number of visits in the outpatient clinic 
• Patient­reported outcome measures (using an 
11­point numeric rating scale). 
Statistics 
Power calculation 
The power calculation was based on the expected 
change in diagnostic accuracy when adding transoral 
ultrasound as point­of­care imaging. 
The sample size needed to compare two indepen­
dent binomial proportions with a significance level of 
0.05 and 90% power was calculated based on a prior 
study that found a difference in diagnostic accuracy of 
28% when comparing transoral ultrasound with  clin­
ical examination [7]. 
Based on the power calculation presented in Table 
2, it was estimated that 44 patients would be needed in 
each group [18]. We therefore aim to include a total of 
88 patients in the study.
Statistical analysis
All enrolled patients are included in the analysis on an 
intention­to­treat basis. For each patient, the diagnostic 
accuracy (correct/false tentative diagnosis) and pro­
portion of successful needle aspirations (aspiration of 
± pus) are analysed as binary data. The mean differ­
ences between the intervention and the control group 
will be compared using binary logistic regression and a 
generalised estimating equation to adjust for clustering 
of data within each physician and each hospital. Nega­
tive binomial distribution will be used to explore the 
differences in sick days and the number of performed 
needle aspirations between the intervention and the 
control group. 
The statistical analyses will be performed using the 
statistical software package (PASW, version 25.0; SPSS 
Inc, Chicago, Illinois, U.S.A.), and two­sided signifi­
cance levels of 0.05 will be used for all analyses.
Inclusion period 
The annual incidence of PTAs is 36 per 100,000 per­
sons [1]. We will include adult patients from two dif­
ferent otorhinolaryngology departments at RH and  
at OUH, covering a population of 916,000 (RH) and 
466,284 (OUH) totalling 1.38 million people. We 
therefore expect 498 patients to be diagnosed with a 
PTA annually within the coverage areas of the two hos­
pitals. Some of these patients will be treated by an of­
fice­based otorhinolaryngologist and some patients will 
decline to participate in the study. We therefore expect 
to include 25% of the 498 potential patients = 125 pa­
tients. We will thus need about nine months to include 
88 patients in the study.
Ethics and data management
Ethical approval was granted in the form of an exemp­
tion letter from the Committee on Biomedical Research 
Ethics of the Capital Region of Denmark (registration 
number: H­18037012). Verbal and written informed 
consent will be obtained from every patient involved. 
All data will be stored on a Research electronic data 
capture (RedCap) Database and documentation re­
quirements and data permission were approved by The 
Capital Region of Denmark (registration number: VD­
2018­361). Data entry will be performed by co­authors 
MGS and SHM, and the statistical analyses will be per­
formed by first author TT who will be blinded to the 
randomisation of the study subjects until the analyses 
of the primary outcome have been completed. The an­
onymised data will be made publicly available through 
the open­access database Zenodo open data repository 
(CERN).
Trial registration: Clinicaltrials NCT03824288.
TABLE 2 / Power calculations to determine 
minimum sample size needed to compare two 
 binomial proportions using a two-sided test with 
significance level 0.05 and power 90%.
parameter calculation
n z1
 – a × 
√ 
px × qx ×
  1+1   + z1-β × √
 p1 × q1 +  
p2 × q2    
2
/∆2
       2                           k                                        k
q1 1 – p1
q2 1 – p2
px p1 + kp2
1+ k
qx 1 – px
α = probability of type I error (= 0.05); β = probability of type II error (= 0.2); Δ = |p2 – p1| = absolute 
difference between 2 proportions; k = ratio of sample size for intervention group no. 2 to control group no. 1;
n = sample size for 1 group, n = {1.96 × √ 0.78 × 0.22 ×  1 + 1    + 1.28 × √ 0.92 × 0.08 +   
0.64 × 0.36
 }
2
 /0.282 = 44;                                                                                                          
1
                                                                                                    1   
p1 = diagnostic accuracy of transoral ultrasound (intervention group); p2 = diagnostic accuracy of clinical examination  
(control group); z = critical Z-value for a given α or β.
{ {
(    ) (   ) 
(     )(  )
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DISCUSSION 
Transoral ultrasound has the potential to improve the 
accuracy of diagnosing peritonsillar abscesses, but pre­
vious studies have methodological deficiencies, and the 
procedure has yet to be included as part of the standard 
diagnostic work­up. A single­centre RCT using trans­
oral ultrasound as static imaging reported promising 
findings, but the study was limited by a small sample 
size. Furthermore, it lacked a description of the train­
ing received by the physicians performing the proced­
ure, which is a relevant parameter since ultrasound is 
very operator dependent [19]. This study will be the 
first multi­centre RCT to explore the clinical effect of 
adding a novel transoral ultrasound technique to the 
diagnostic work­up of patients with peritonsillar infec­
tion. Our results will have the potential to improve 
both the diagnosis and treatment thereby avoiding un­
necessary interventions and hospitalizations in the  
future.
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